Raymond M. Baker

1.9k total citations
38 papers, 1.6k citations indexed

About

Raymond M. Baker is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Raymond M. Baker has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Genetics. Recurrent topics in Raymond M. Baker's work include DNA Repair Mechanisms (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Raymond M. Baker is often cited by papers focused on DNA Repair Mechanisms (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Raymond M. Baker collaborates with scholars based in United States, Canada and India. Raymond M. Baker's co-authors include Larry H. Thompson, Ralph Mankovitz, Louis Siminovitch, G. F. Whitmore, J. E. Till, Victor Ling, D. M. Brunette, Harry K. Slocum, Youcef M. Rustum and Manuel Buchwald and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Raymond M. Baker

38 papers receiving 1.4k citations

Peers

Raymond M. Baker

ONCOL

GENET

SURGE

Peter W. Melera United States

J. G. Holland United States

Merrill E. Goldsmith United States

Benjamin T. Vroman United States

Wayne F. Flintoff Canada

H. Green United States

Philip Hedge United Kingdom

Esther W. Hou United States

Cheng‐Wen Wu Taiwan

Gary B. Henderson United States

Peter W. Melera United States

Raymond M. Baker

1.2k ×1.0

802 ×1.8

ONCOL

87 ×0.4

159 ×0.8

GENET

103 ×0.7

SURGE

Citations per year, relative to Raymond M. Baker Raymond M. Baker (= 1×) peers Peter W. Melera

Countries citing papers authored by Raymond M. Baker

Since Specialization

Citations

This map shows the geographic impact of Raymond M. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond M. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond M. Baker more than expected).

Fields of papers citing papers by Raymond M. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond M. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond M. Baker. The network helps show where Raymond M. Baker may publish in the future.

Co-authorship network of co-authors of Raymond M. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond M. Baker. A scholar is included among the top collaborators of Raymond M. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond M. Baker. Raymond M. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganeshaguru, K., et al.. (2003). Multidrug resistance and myelomonocytic leukaemia in gaucher's disease.. PubMed. 88(2). ECR02–ECR02. 4 indexed citations

Baker, Raymond M., et al.. (1994). Subclonal heterogeneity of the multidrug resistance phenotype in a cell line expressing antisense MDR1 RNA. Somatic Cell and Molecular Genetics. 20(6). 463–480. 5 indexed citations

Tóth, Károly, Mary M. Vaughan, Harry K. Slocum, et al.. (1994). New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.. PubMed. 144(2). 227–36. 45 indexed citations

Chervinsky, David S., et al.. (1993). Reversal of C1300 Murine Neuroblastoma Multidrug Resistance by CremophorEL, A Solvent for Cyclosporin A. PubMed. 8(1). 67–75. 11 indexed citations

Iversen, L L, Susan D. Iversen, Stephen B. Freedman, et al.. (1993). Approaches to rational drug development in Alzheimer's disease.. PubMed. 9(3-4). 251–9. 5 indexed citations

Beerman, Terry A., et al.. (1992). Resistance of CHO cells expressing P-glycoprotein to cyclopropylpyrroloindole (CPI) alkylating agents. Biochemical Pharmacology. 43(8). 1817–1822. 13 indexed citations

Woynarowski, Jan M., et al.. (1991). Induction of heat-labile sites in DNA of mammalian cells by the antitumor alkylating drug CC-1065. Biochemistry. 30(15). 3733–3738. 20 indexed citations

Tebbi, Cameron K., David S. Chervinsky, & Raymond M. Baker. (1991). Modulation of drug resistance in homoharringtonine‐resistant C‐1300 neuroblastoma cells with cyclosporine A and dipyridamole. Journal of Cellular Physiology. 148(3). 464–471. 8 indexed citations

Baker, Raymond M., et al.. (1990). Detection of P-Glycoprotein in Human Tumors. Cancer Investigation. 8(2). 255–256. 3 indexed citations

10.

Fredericks, William J., et al.. (1990). P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells. Cancer Chemotherapy and Pharmacology. 25(4). 241–246. 12 indexed citations

11.

Rauscher, Frank J., Terry A. Beerman, & Raymond M. Baker. (1990). Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.. Molecular Pharmacology. 38(2). 198–206. 1 indexed citations

12.

Gerlach, James H., David R. Bell, Constantine P. Karakousis, et al.. (1987). P-glycoprotein in human sarcoma: evidence for multidrug resistance.. Journal of Clinical Oncology. 5(9). 1452–1460. 226 indexed citations

13.

Baker, Raymond M., et al.. (1982). [40] Isolation of somatic cell glycoprotein mutants. Methods in enzymology on CD-ROM/Methods in enzymology. 83. 444–458. 8 indexed citations

14.

Cavenee, Webster K. & Raymond M. Baker. (1982). Characterization of dominant hamster cell mutants resistant to oxygenated sterols. Somatic Cell and Molecular Genetics. 8(5). 557–574. 4 indexed citations

15.

Hirschberg, C B, et al.. (1981). Selection of mutant Chinese hamster ovary cells altered glycoproteins by means of tritiated fucose suicide.. Molecular and Cellular Biology. 1(10). 902–909. 20 indexed citations

16.

Ling, Victor & Raymond M. Baker. (1978). Dominance of colchicine resistance in hybrid CHO cells. Somatic Cell and Molecular Genetics. 4(2). 193–200. 46 indexed citations

17.

Krag, Sharon S., Maria Grazia Cifone, Phillips W. Robbins, & Raymond M. Baker. (1977). Reduced synthesis of [14C]mannosyl oligosaccharide-lipid by membranes prepared from concanavalin A-resistant Chinese hamster ovary cells.. Journal of Biological Chemistry. 252(10). 3561–3564. 37 indexed citations

18.

Mankovitz, Ralph, Manuel Buchwald, & Raymond M. Baker. (1974). Isolation of ouabain-resistant human diploid fibroblasts. Cell. 3(3). 221–226. 104 indexed citations

19.

Thompson, Larry H. & Raymond M. Baker. (1973). Chapter 7: Isolation of Mutants of Cultured Mammalian Cells. Methods in cell biology. 6. 209–281. 196 indexed citations

20.

Baker, Raymond M. & Robert H. Haynes. (1972). Recombination of parental lambda phages labeled by means of host-controlled modification. Virology. 50(1). 1–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact